GHK-Cu 100mg
GHK-Cu is a naturally occurring copper-binding tripeptide consisting of the amino acid sequence glycine-histidine-lysine (Gly-His-Lys) coordinated to a copper(II) ion. Its molecular formula is C14H21CuN6O4, molecular weight 404.9 g/mol, and CAS registry number 89030-95-5. In purified form, the compound presents as a blue crystalline powder — a visual property that arises directly from the chelated copper center, which absorbs light in the orange-red wavelengths. GHK-Cu was first characterized in 1973 by researcher Loren Pickart while studying biological activity differences between plasma samples from donors of varying ages. His initial observations noted that plasma from younger individuals retained a greater capacity to support certain hepatic cell functions, and subsequent fractionation identified this copper-tripeptide complex as the key differentiating factor. GHK-Cu is endogenously present in human plasma, saliva, and urine at trace concentrations, and circulating levels appear to change across the lifespan. The copper ion in GHK-Cu is coordinated through the nitrogen atoms of the glycine amino terminus and the imidazole ring of the histidine residue, forming a stable square-planar complex. This metal-peptide coordination places GHK-Cu in a relatively unusual structural category among short peptides. The chelated copper(II) center gives the compound distinct physicochemical behavior compared to the uncomplexed tripeptide Gly-His-Lys, including high water solubility, a characteristic absorption spectrum in the visible range, and improved stability under standard laboratory conditions. Published research involving GHK-Cu spans multiple scientific disciplines, including dermatology, wound biology, extracellular matrix biology, and aging research. Peer-reviewed studies have examined the compound's interactions with dermal fibroblasts, collagen-remodeling enzymes, antioxidant gene networks, and various cell surface receptors in cell-culture systems. This compound is supplied as a lyophilized powder for laboratory research use only by qualified professionals. It is not intended for human or veterinary use, nor for use in clinical diagnostic or therapeutic applications.
$75.00
GHK-Cu is a naturally occurring copper-binding tripeptide consisting of the amino acid sequence glycine-histidine-lysine (Gly-His-Lys) coordinated to a copper(II) ion.
Need a larger quantity? Contact us for custom bulk pricing.
Volume Discounts
Researcher Account Required
Create a free researcher account to place orders.
ITide+ Laboratories sells exclusively to verified researchers. All products are Research Use Only (RUO) — for laboratory research use only, diagnostic use, or therapeutic application.
By creating an account you confirm you are a qualified researcher and will use these compounds in accordance with all applicable laws and regulations.
For laboratory research purposes only by qualified professionals. This product has not been evaluated by the FDA for clinical application.
- ✓ 99.73% Purity — Third-Party COA Verified
- ✓ CAS: 89030-95-5
- ✓ Lyophilized powder, research grade
- ✓ For laboratory research use by qualified professionals
Certificate of Analysis
Every ITide Labs batch is verified by independent third-party laboratory analysis for purity and identity before release.
Endo PassedGHK-Cu is a naturally occurring copper-binding tripeptide consisting of the amino acid sequence glycine-histidine-lysine (Gly-His-Lys) coordinated to a copper(II) ion. Its molecular formula is C14H21CuN6O4, molecular weight 404.9 g/mol, and CAS registry number 89030-95-5. In purified form, the compound presents as a blue crystalline powder — a visual property that arises directly from the chelated copper center, which absorbs light in the orange-red wavelengths.
GHK-Cu was first characterized in 1973 by researcher Loren Pickart while studying biological activity differences between plasma samples from donors of varying ages. His initial observations noted that plasma from younger individuals retained a greater capacity to support certain hepatic cell functions, and subsequent fractionation identified this copper-tripeptide complex as the key differentiating factor. GHK-Cu is endogenously present in human plasma, saliva, and urine at trace concentrations, and circulating levels appear to change across the lifespan.
The copper ion in GHK-Cu is coordinated through the nitrogen atoms of the glycine amino terminus and the imidazole ring of the histidine residue, forming a stable square-planar complex. This metal-peptide coordination places GHK-Cu in a relatively unusual structural category among short peptides. The chelated copper(II) center gives the compound distinct physicochemical behavior compared to the uncomplexed tripeptide Gly-His-Lys, including high water solubility, a characteristic absorption spectrum in the visible range, and improved stability under standard laboratory conditions.
Published research involving GHK-Cu spans multiple scientific disciplines, including dermatology, wound biology, extracellular matrix biology, and aging research. Peer-reviewed studies have examined the compound's interactions with dermal fibroblasts, collagen-remodeling enzymes, antioxidant gene networks, and various cell surface receptors in cell-culture systems. This compound is supplied as a lyophilized powder for laboratory research use only by qualified professionals. It is not intended for human or veterinary use, nor for use in clinical diagnostic or therapeutic applications.
For laboratory research purposes only by qualified professionals. This product has not been evaluated by the FDA for clinical application.
For laboratory research purposes only by qualified professionals. This product has not been evaluated by the FDA for clinical application.
Additional information
| Weight | 0.1 lbs |
|---|---|
| Dimensions | 12 × 15 × 0.5 in |
| Size | 100mg |
